Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.

Single-cell multiomics analysis reveals regulatory programs in clear cell renal cell carcinoma

Open access

Abstract

The clear cell renal cell carcinoma (ccRCC) microenvironment consists of many different cell types and structural components that play critical roles in cancer progression and drug resistance, but the cellular architecture and underlying gene regulatory features of ccRCC have not been fully characterized. Here, we applied single-cell RNA sequencing (scRNA-seq) and single-cell assay for transposase-accessible chromatin sequencing (scATAC-seq) to generate transcriptional and epigenomic landscapes of ccRCC. We identified tumor cell-specific regulatory programs mediated by four key transcription factors (TFs) (HOXC5, VENTX, ISL1, and OTP), and these TFs have prognostic significance in The Cancer Genome Atlas (TCGA) database. Targeting these TFs via short hairpin RNAs (shRNAs) or small molecule inhibitors decreased tumor cell proliferation. We next performed an integrative analysis of chromatin accessibility and gene expression for CD8+ T cells and macrophages to reveal the different regulatory elements in their subgroups. Furthermore, we delineated the intercellular communications mediated by ligand–receptor interactions within the tumor microenvironment. Taken together, our multiomics approach further clarifies the cellular heterogeneity of ccRCC and identifies potential therapeutic targets.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41421-022-00415-0

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Single-cell transcriptional and chromatin accessibility profiling of human ccRCC. a Schematic of multiomics profiling of chromatin accessibility and transcription in ccRCC using scRNA-seq and scATAC-seq. b scRNA-seq UMAP projection of 38,097 single cells from four ccRCC samples. c Dot plot showing the gene expression patterns of cell-type marker genes in the scRNA-seq data. d Cross-platform linkage of scATAC-seq cells with scRNA-seq cells. e scATAC-seq UMAP projection of 21,272 single cells from three ccRCC samples. f Normalized chromatin accessibility profiles for each cell type at canonical marker genes. The promoter region is highlighted in gray with the gene model and chromosome position shown below. g Heatmap of CNV signals normalized against the “normal” cluster shown in the top panel (CD8+ T cells and NK/NKT cells) for CNV changes by chromosome (columns) within individual cells (rows). All cells in the tumor population (bottom panel) exhibited chromosome 3p loss (blue dotted frame) or chromosome 5q gain (red dotted frame), which are classic genomic features of ccRCC. h Pie charts of the proportion of each class in the scRNA-seq and scATAC-seq dataset.
Fig. 1 Single-cell transcriptional and chromatin accessibility profiling of human ccRCC. a Schematic of multiomics profiling of chromatin accessibility and transcription in ccRCC using scRNA-seq and scATAC-seq. b scRNA-seq UMAP projection of 38,097 single cells from four ccRCC samples. c Dot plot showing the gene expression patterns of cell-type marker genes in the scRNA-seq data. d Cross-platform linkage of scATAC-seq cells with scRNA-seq cells. e scATAC-seq UMAP projection of 21,272 single cells from three ccRCC samples. f Normalized chromatin accessibility profiles for each cell type at canonical marker genes. The promoter region is highlighted in gray with the gene model and chromosome position shown below. g Heatmap of CNV signals normalized against the “normal” cluster shown in the top panel (CD8+ T cells and NK/NKT cells) for CNV changes by chromosome (columns) within individual cells (rows). All cells in the tumor population (bottom panel) exhibited chromosome 3p loss (blue dotted frame) or chromosome 5q gain (red dotted frame), which are classic genomic features of ccRCC. h Pie charts of the proportion of each class in the scRNA-seq and scATAC-seq dataset.CC BY · PubMed Central
Fig. 2 Identification of tumor-specific regulatory elements. a Heatmap of the Z-score normalized accessibilities of 22,682 scATAC-seq differential peaks for each cell type. b Pie plot of genomic annotations for scATAC-seq differential peaks. c Gene ontology term enrichment analysis for distal (intergenic region) and proximal (promoter and gene body) upregulated DARs in tumor cells. The Benjamini-Hochberg adjusted P values are shown on the right side of the plots. d Heatmap representation of chromVAR bias-corrected deviation scores for the differential TF motifs of each cell type. The top TF motifs of each cell type are indicated on both sides of the plot. e Heatmap of the log2(FC) values for tumor-specific TFs identified by our filtering strategy. The right bar plot shows the Bonferroni-adjusted P values. f Kaplan–Meier overall survival curves of TCGA-KIRC patients grouped by the average expression of tumor-specific TFs (with the median value as the threshold). HR hazard ratio.
Fig. 2 Identification of tumor-specific regulatory elements. a Heatmap of the Z-score normalized accessibilities of 22,682 scATAC-seq differential peaks for each cell type. b Pie plot of genomic annotations for scATAC-seq differential peaks. c Gene ontology term enrichment analysis for distal (intergenic region) and proximal (promoter and gene body) upregulated DARs in tumor cells. The Benjamini-Hochberg adjusted P values are shown on the right side of the plots. d Heatmap representation of chromVAR bias-corrected deviation scores for the differential TF motifs of each cell type. The top TF motifs of each cell type are indicated on both sides of the plot. e Heatmap of the log2(FC) values for tumor-specific TFs identified by our filtering strategy. The right bar plot shows the Bonferroni-adjusted P values. f Kaplan–Meier overall survival curves of TCGA-KIRC patients grouped by the average expression of tumor-specific TFs (with the median value as the threshold). HR hazard ratio.CC BY · PubMed Central
Fig. 3 Characterization of the four tumor-specific TFs. a Kaplan–Meier analyses of overall survival in TCGA-KIRC patients separated by HOXC5, VENTX, ISL1, and OTP expression (with the median value as the threshold) individually. HR, hazard ratio. b TF regulatory network showing the candidate target genes for the following TFs: HOXC5, VENTX, ISL1, and OTP in tumor cells. c The effects of sh-HOXC5, VENTX, ISL1, OTP, and vector on cell proliferation were determined by a cell proliferation assay in the 786-O cell line. d HOXC5, VENTX, ISL1, and OTP mRNA expression were significantly downregulated in the 786-O cell line. Significance was determined by two-way ANOVA. e Heatmap showing the degree of decrease in expression levels of VENTX, ISL1, and HOXC5 after drug treatment. f Cell proliferation was assessed over a 2-day time course after treatment with DMSO or HHT in the 786-O (top) and 769-P (bottom) ccRCC cell lines. Significance was determined by multiple t-tests. g The mRNA levels of HOXC5 after treatment with DMSO or HHT in the 786-O (left) and 769-P (right) ccRCC cell lines were measured using qPCR. Significance was determined by Student’s t-test. h Cell proliferation was assessed over a 2-day time course after treatment with DMSO or mitotane in the 786-O (top) and 769-P (bottom) ccRCC cell lines. Significance was determined by multiple t-tests. i The mRNA levels of VENTX after treatment with DMSO or mitotane in the 786-O (left) and 769-P (right) ccRCC cell lines were measured using qPCR. Significance was determined by Student’s t-test. j The mRNA levels of ISL1 after treatment with DMSO or mitotane in the 786-O (left) and 769-P (right) ccRCC cell lines were measured using qPCR. Significance was determined by Student’s t-test. For all statistical tests, *P < 0.05; **P < 0.01; ***P < 0.001.
Fig. 3 Characterization of the four tumor-specific TFs. a Kaplan–Meier analyses of overall survival in TCGA-KIRC patients separated by HOXC5, VENTX, ISL1, and OTP expression (with the median value as the threshold) individually. HR, hazard ratio. b TF regulatory network showing the candidate target genes for the following TFs: HOXC5, VENTX, ISL1, and OTP in tumor cells. c The effects of sh-HOXC5, VENTX, ISL1, OTP, and vector on cell proliferation were determined by a cell proliferation assay in the 786-O cell line. d HOXC5, VENTX, ISL1, and OTP mRNA expression were significantly downregulated in the 786-O cell line. Significance was determined by two-way ANOVA. e Heatmap showing the degree of decrease in expression levels of VENTX, ISL1, and HOXC5 after drug treatment. f Cell proliferation was assessed over a 2-day time course after treatment with DMSO or HHT in the 786-O (top) and 769-P (bottom) ccRCC cell lines. Significance was determined by multiple t-tests. g The mRNA levels of HOXC5 after treatment with DMSO or HHT in the 786-O (left) and 769-P (right) ccRCC cell lines were measured using qPCR. Significance was determined by Student’s t-test. h Cell proliferation was assessed over a 2-day time course after treatment with DMSO or mitotane in the 786-O (top) and 769-P (bottom) ccRCC cell lines. Significance was determined by multiple t-tests. i The mRNA levels of VENTX after treatment with DMSO or mitotane in the 786-O (left) and 769-P (right) ccRCC cell lines were measured using qPCR. Significance was determined by Student’s t-test. j The mRNA levels of ISL1 after treatment with DMSO or mitotane in the 786-O (left) and 769-P (right) ccRCC cell lines were measured using qPCR. Significance was determined by Student’s t-test. For all statistical tests, *P < 0.05; **P < 0.01; ***P < 0.001.CC BY · PubMed Central
Fig. 4 Deciphering malignant transcriptional programs within ccRCC. a Pairwise correlations between the expression profiles of four scRNA-seq samples (3564 cells). b Heatmap of average correlations across four samples between pairs of programs. c Dot plot showing significantly enriched pathways for signature genes of each meta-program. The color shade of the dot indicates the P value after FDR correction (the redder, the smaller adjusted P value), and the size of the dot represents the number of genes in the indicated pathway (the larger, the more genes included). d, e The Kaplan–Meier overall survival curves of TCGA-KIRC patients grouped by the average gene expression of meta-program 1 and meta-program 2 (with the median as the threshold). The P value was calculated by the log-rank test. HR, hazard ratio. f, g Sankey diagrams showing the regulatory relationship between the four tumor-specific TFs and genes within meta-program 1 and meta-program 2.
Fig. 4 Deciphering malignant transcriptional programs within ccRCC. a Pairwise correlations between the expression profiles of four scRNA-seq samples (3564 cells). b Heatmap of average correlations across four samples between pairs of programs. c Dot plot showing significantly enriched pathways for signature genes of each meta-program. The color shade of the dot indicates the P value after FDR correction (the redder, the smaller adjusted P value), and the size of the dot represents the number of genes in the indicated pathway (the larger, the more genes included). d, e The Kaplan–Meier overall survival curves of TCGA-KIRC patients grouped by the average gene expression of meta-program 1 and meta-program 2 (with the median as the threshold). The P value was calculated by the log-rank test. HR, hazard ratio. f, g Sankey diagrams showing the regulatory relationship between the four tumor-specific TFs and genes within meta-program 1 and meta-program 2.CC BY · PubMed Central
Fig. 5 Characterization of CD8+ T cells in ccRCC. a, b Subclustering of CD8+ T cells on the UMAP plots of the scRNA-seq and scATAC-seq datasets. c Heatmap of CD8+ T cell lineage and functional markers provided phenotypic information for individual CD8+ T cell clusters in the scRNA-seq (left) and scATAC-seq (right) data. d, e Violin plots showing the signature scores of cytotoxic and exhaustion gene sets for each CD8+ T cell cluster in the scRNA-seq (top) and scATAC-seq data (bottom). Signature scores for each cell were calculated by the VISION method. Two-sided Wilcoxon test. ns, no significance; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. f Violin plots showing the progenitor and terminally exhausted signature scores for each CD8+ T cell cluster in the scRNA-seq data. Signature scores for each cell were calculated by the VISION method. Two-sided Wilcoxon test. ns, no significance; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. g Heatmap of significantly enriched pathways for DEGs of each CD8+ T cell cluster in the scRNA-seq data. The darker the red color is, the smaller the adjusted P value. h Dot plot showing the top enriched TFs within each CD8+ T cell subpopulation individually.
Fig. 5 Characterization of CD8+ T cells in ccRCC. a, b Subclustering of CD8+ T cells on the UMAP plots of the scRNA-seq and scATAC-seq datasets. c Heatmap of CD8+ T cell lineage and functional markers provided phenotypic information for individual CD8+ T cell clusters in the scRNA-seq (left) and scATAC-seq (right) data. d, e Violin plots showing the signature scores of cytotoxic and exhaustion gene sets for each CD8+ T cell cluster in the scRNA-seq (top) and scATAC-seq data (bottom). Signature scores for each cell were calculated by the VISION method. Two-sided Wilcoxon test. ns, no significance; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. f Violin plots showing the progenitor and terminally exhausted signature scores for each CD8+ T cell cluster in the scRNA-seq data. Signature scores for each cell were calculated by the VISION method. Two-sided Wilcoxon test. ns, no significance; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. g Heatmap of significantly enriched pathways for DEGs of each CD8+ T cell cluster in the scRNA-seq data. The darker the red color is, the smaller the adjusted P value. h Dot plot showing the top enriched TFs within each CD8+ T cell subpopulation individually.CC BY · PubMed Central
Fig. 6 Characterization of TAMs in ccRCC. a, b Subclustering of TAMs on the UMAP plots of the scRNA-seq and scATAC-seq datasets. c Dot plot showing the expression levels and activity scores for known phenotypic markers in each TAM cluster. Dot size indicates the fraction of expressing cells, colored based on normalized expression or activity. d Heatmap showing the expression of MHC molecules, chemokines, cytokines, and other related genes in each TAM cluster. e Boxplots showing the M1 and M2 signature scores for each TAM cluster in the scRNA-seq data. The signature score was calculated by the VISION method. Two-sided Wilcoxon test. ns, no significance; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. f, g Boxplot showing the angiogenesis and phagocytosis signature scores for each TAM cluster in the scRNA-seq data. The signature score was calculated by the VISION method. Two-sided Wilcoxon test. ns, no significance; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. h Dot plot showing the expression of the immune costimulatory, checkpoint, and evasion genes for each TAM cluster in the scRNA-seq dataset. i Heatmap of log2(FC) values for TFs with significant differences both in the scRNA-seq and scATAC-seq datasets. j TF regulatory network showing the predicted target genes for MEF2C in the TAM-C1QB cluster.
Fig. 6 Characterization of TAMs in ccRCC. a, b Subclustering of TAMs on the UMAP plots of the scRNA-seq and scATAC-seq datasets. c Dot plot showing the expression levels and activity scores for known phenotypic markers in each TAM cluster. Dot size indicates the fraction of expressing cells, colored based on normalized expression or activity. d Heatmap showing the expression of MHC molecules, chemokines, cytokines, and other related genes in each TAM cluster. e Boxplots showing the M1 and M2 signature scores for each TAM cluster in the scRNA-seq data. The signature score was calculated by the VISION method. Two-sided Wilcoxon test. ns, no significance; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. f, g Boxplot showing the angiogenesis and phagocytosis signature scores for each TAM cluster in the scRNA-seq data. The signature score was calculated by the VISION method. Two-sided Wilcoxon test. ns, no significance; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. h Dot plot showing the expression of the immune costimulatory, checkpoint, and evasion genes for each TAM cluster in the scRNA-seq dataset. i Heatmap of log2(FC) values for TFs with significant differences both in the scRNA-seq and scATAC-seq datasets. j TF regulatory network showing the predicted target genes for MEF2C in the TAM-C1QB cluster.CC BY · PubMed Central
Fig. 7 Ligand–receptor-based interaction between tumor and immune cells. a Heatmap of the number of significant ligand–receptor interactions between cell types in the scRNA-seq data. b The interaction network between the tumor cell and other cell types. The direction of the arrow indicates the cell type expressing the receptor. The wider the edge or larger the dot is, the greater the number of interactions. c Heatmap of the number of significant interactions mediated by tumor cells as ligand-expressing and receptor-expressing cells. d Dot plots showing the mean interaction strength for selected ligand–receptor pairs between tumor cells and TAM clusters. The left and right plots show that the ligand is expressed in the tumor cells and TAM clusters, respectively. Dot size indicates the P value, colored by the average expression level of interacting molecule 1 in cluster 1 and interacting molecule 2 in cluster 2. e The Kaplan–Meier overall survival curves of TCGA-KIRC patients grouped by the averaged expression of RPS19 and C5AR1 (with the median value as the threshold). HR, hazard ratio. f Dot plots showing the mean interaction strength for selected ligand–receptor pairs between tumor cells and three lymphoid subsets. The left and right plots show that the ligand is expressed in the tumor cells and lymphoid subsets, respectively. Dot size indicates the P value, colored by the average expression level of interacting molecule 1 in cluster 1 and interacting molecule 2 in cluster 2. g Kaplan–Meier overall survival curves of TCGA-KIRC patients grouped by the averaged expression of LTB and LTBR (with the median value as the threshold).
Fig. 7 Ligand–receptor-based interaction between tumor and immune cells. a Heatmap of the number of significant ligand–receptor interactions between cell types in the scRNA-seq data. b The interaction network between the tumor cell and other cell types. The direction of the arrow indicates the cell type expressing the receptor. The wider the edge or larger the dot is, the greater the number of interactions. c Heatmap of the number of significant interactions mediated by tumor cells as ligand-expressing and receptor-expressing cells. d Dot plots showing the mean interaction strength for selected ligand–receptor pairs between tumor cells and TAM clusters. The left and right plots show that the ligand is expressed in the tumor cells and TAM clusters, respectively. Dot size indicates the P value, colored by the average expression level of interacting molecule 1 in cluster 1 and interacting molecule 2 in cluster 2. e The Kaplan–Meier overall survival curves of TCGA-KIRC patients grouped by the averaged expression of RPS19 and C5AR1 (with the median value as the threshold). HR, hazard ratio. f Dot plots showing the mean interaction strength for selected ligand–receptor pairs between tumor cells and three lymphoid subsets. The left and right plots show that the ligand is expressed in the tumor cells and lymphoid subsets, respectively. Dot size indicates the P value, colored by the average expression level of interacting molecule 1 in cluster 1 and interacting molecule 2 in cluster 2. g Kaplan–Meier overall survival curves of TCGA-KIRC patients grouped by the averaged expression of LTB and LTBR (with the median value as the threshold).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 102 references

Cited by

See all 130

Metadata

Authors
Long, Z., Sun, C., Tang, M., Wang, Y., Ma, J., Yu, J., Wei, J., Ma, J., Wang, B., Xie, Q., & Wen, J.
Affiliations
  • Westlake University (CN)
  • Second Affiliated Hospital of Zhejiang University (CN)
  • University of California San Diego (US)
  • Peking University (CN)
Corresponding author
  • Wang, Bohan
  • Xie, Qi
  • Wen, Jiaming
Venue
Cell Discovery
Published
2022-07-19
Volume
8
Issue
1
Pages
68-68
ISSN
2056-5968 (ISSN-L)
OpenAlex
W4285795954
Cited by
109
References
102
Citations by year
2026: 18 · 2025: 27 · 2024: 36 · 2023: 23 · 2022: 5
FWCI
18.07
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Discovery (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
Funders
  • National Natural Science Foundation of China (82073268, 81970601, 81871153)
  • Westlake Education Foundation
Topics
  • Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
clear cell renal cell carcinoma, tumor microenvironment, transcription factors, chromatin accessibility, epigenomics, Isl1, OTP, CD8+ T cells, tumor-associated macrophages, intercellular communication, ligand-receptor interactions, tumor cell proliferation, cellular heterogeneity, therapeutic target

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Single-cell multiomics analysis reveals regulatory programs in clear cell renal cell carcinoma. https://app.cochat.ai/papers/10.1038/s41421-022-00415-0
The paper
Long, Z., Sun, C., Tang, M., Wang, Y., Ma, J., Yu, J., Wei, J., Ma, J., Wang, B., Xie, Q., & Wen, J. (2022). Single-cell multiomics analysis reveals regulatory programs in clear cell renal cell carcinoma. Cell Discovery. https://doi.org/10.1038/s41421-022-00415-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.